Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Aaron Kantor, Frank Torti

Aaron Kantor, Frank Torti

Apr 10, 2008
Premium
The Immune Tolerance Institute this week said Aaron Kantor joined the company as chief scientific officer.
 
Prior to ITI, Kantor was executive director of cell and molecular biology for biomarker discovery sciences at Pharmaceutical Product Development, a contract research organization. Before that, he was manager for the rare cell program and cell depletion therapeutic program at AmCell.
 
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

High Numbers Reported for Russian Vaccine

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Masterpiece Microbiome

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

Limited Trust

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

Nucleic Acids Research Papers on Aging Atlas, Human Metagenomes, Drug Repositioning

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

What's Popular?

In Proteomics & Protein Research

  1. Somalogic Closes $121M Series A Funding

  2. UW-Madison Team Devises Workflow For LC-Free Proteomics

    Premium

  3. Correlia Biosystems Closes $7M Series A Round

  4. Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.